
Few lawyers can match Ralph Pittle’s depth of experience working on
drug-caused tardive dyskinesia. Here are a few milestones and
highlights from his quarter century of working directly with these
kinds of TD cases.
 |
In 1985, Ralph took his first case of drug-induced tardive
dyskinesia. He won a settlement for that client. |
 |
In 1989, Ralph pursued the first case in the United States
against the A.H. Robins Company and American Home Product
Corporation, the manufacturers of Reglan, involving Reglan-induced
tardive dyskinesia. A court ruled that her doctor should have told
her the risks. |
 |
Ralph’s leadership led to his being elected co-chairman of the
Tardive Dyskinesia Litigation Group at the Association of Trial
Lawyers of America. (now known as the American Association for
Justice). |
 |
Ralph’s team secured the right to use the full document
discovery and deposition testimony it acquired from A.H. Robins,
Wyeth and generic manufacturers on early cases in all future cases
where he is part of the client’s team, which could greatly benefit
his clients. |
 |
Ralph can offer new clients a well-grounded estimate of what
their case might be worth based on his 20-year history of fighting
Reglan and generic metoclopramide cases. |
 |
Ralph led a team of lawyers that secured landmark rulings from
Courts of Appeals in Washington, Texas and California that greatly
boost his Reglan clients’ ability to win substantial cash
settlements. |
|